Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-Defensin-2, Human β-Defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin

American Journal of Pathology

Volumn 182, Issue 5, 2013, Pages 1705-1717

  Hau, Carren S ^a,b   Kanda, Naoko ^a   Noda, Shinji ^b   Tatsuta, Aya ^b   Kamata, Masahiro ^b   Shibata, Sayaka ^b   Asano, Yoshihide ^b   Sato, Shinichi ^b   Watanabe, Shinichi ^a   Tada, Yayoi ^b  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CCAAT BINDING FACTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; IMIQUIMOD; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PSORIASIN; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PSORIASIS;

AMINOQUINOLINES; ANIMALS; BETA-DEFENSINS; CATHELICIDINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; HUMANS; KERATINOCYTES; MICE; MICE, INBRED BALB C; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PSORIASIS; RECEPTOR, INSULIN; RNA, MESSENGER; RNA, SMALL INTERFERING; S100 PROTEINS; SKIN; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84876574624     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.01.044     Document Type: Article

References (39)

1. F.O. Nestle, P. Di Meglio, J.Z. Qin, and B.J. Nickoloff Skin immune sentinels in health and disease Nat Rev Immunol 9 2009 679 691
2. M.A. Lowes, T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L.C. Zaba, A.S. Haider, E.P. Bowman, and J.G. Krueger Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 2008 1207 1211
3. F.O. Nestle, D.H. Kaplan, and J. Barker Psoriasis N Engl J Med 361 2009 496 509
4. G.J. de Jongh, P.L. Zeeuwen, M. Kucharekova, R. Pfundt, P.G. van der Valk, W. Blokx, A. Dogan, P.S. Hiemstra, P.C. van de Kerkhof, and J. Schalkwijk High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis J Invest Dermatol 125 2005 1163 1173
5. J. Schauber, and R.L. Gallo Antimicrobial peptides and the skin immune defense system J Allergy Clin Immunol 122 2008 261 266
6. K.O. Kisich, M.D. Howell, M. Boguniewicz, H.R. Heizer, N.U. Watson, and D.Y. Leung The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on β-defensin 3 J Invest Dermatol 127 2007 2368 2380
7. J.G. Dinulos, L. Mentele, L.P. Fredericks, B.A. Dale, and G.L. Darmstadt Keratinocyte expression of human β-defensin 2 following bacterial infection: role in cutaneous host defense Clin Diagn Lab Immunol 10 2003 161 166
8. R. Gläser, J. Harder, H. Lange, J. Bartels, E. Christophers, and J.M. Schröder Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection Nat Immunol 6 2005 57 64
9. S. Morizane, K. Yamasaki, B. Mühleisen, P.F. Kotol, M. Murakami, Y. Aoyama, K. Iwatsuki, T. Hata, and R.L. Gallo Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands J Invest Dermatol 132 2012 135 143
10. R. Lande, J. Gregorio, V. Facchinetti, B. Chatterjee, Y.H. Wang, B. Homey, W. Cao, Y.H. Wang, B. Su, F.O. Nestle, T. Zal, I. Mellman, J.M. Schröder, Y.J. Liu, and M. Gilliet Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide Nature 449 2007 564 569
11. D. Yang, O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, J. Shogan, M. Anderson, J.M. Schröder, J.M. Wang, O.M. Howard, and J.J. Oppenheim Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525 528
12. F. Niyonsaba, H. Ushio, N. Nakano, W. Ng, K. Sayama, K. Hashimoto, I. Nagaoka, K. Okumura, and H. Ogawa Antimicrobial peptides human β-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines J Invest Dermatol 27 2007 594 604
13. Y. Zheng, F. Niyonsaba, H. Ushio, S. Ikeda, I. Nagaoka, K. Okumura, and H. Ogawa Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation Immunology 124 2008 357 367
14. S. Bremmer, A.S. Van Voorhees, S. Hsu, N.J. Korman, M.G. Lebwohl, M. Young, B.F. Bebo Jr., A. Blauvelt National Psoriasis Foundation Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation J Am Acad Dermatol 63 2010 1058 1069
15. A.A. Cerman, S. Bozkurt, A. Sav, A. Tulunay, M.O. Elbaşi, and T. Ergun Serum leptin levels, skin leptin and leptin receptor expression in psoriasis Br J Dermatol 159 2008 820 826
16. A.R. Moschen, A. Kaser, B. Enrich, B. Mosheimer, M. Theurl, H. Niederegger, and H. Tilg Visfatin, an adipocytokine with proinflammatory and immunomodulating properties J Immunol 178 2007 1748 1758
17. M. Tanaka, M. Nozaki, A. Fukuhara, K. Segawa, N. Aoki, M. Matsuda, R. Komuro, and I. Shimomura Visfatin is released from 3T3-L1 adipocytes via a non-classical pathway Biochem Biophys Res Commun 359 2007 194 201
18. S. Gerdes, S. Osadtschy, M. Rostami-Yazdi, N. Buhles, M. Weichenthal, and U. Mrowietz Leptin, adiponectin, visfatin and retinol-binding protein-4: mediators of comorbidities in patients with psoriasis? Exp Dermatol 21 2012 43 47
19. S.A. Ismail, and S.A. Mohamed Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity Br J Dermatol 167 2012 436 439
20. J.Y. Kim, Y.H. Bae, M.K. Bae, S.R. Kim, H.J. Park, H.J. Wee, and S.K. Bae Visfatin through STAT3 activation enhances IL-6 expression that promotes endothelial angiogenesis Biochim Biophys Acta 1793 2009 1759 1767
21. N. Kanda, C.S. Hau, Y. Tada, A. Tatsuta, S. Sato, and S. Watanabe Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes Endocrinology 152 2011 3155 3164
22. L. van der Fits, S. Mourits, J.S. Voerman, M. Kant, L. Boon, J.D. Laman, F. Cornelissen, A.M. Mus, E. Florencia, E.P. Prens, and E. Lubberts Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis J Immunol 182 2009 5836 5845
23. N. Kanda, and S. Watanabe Histamine enhances the production of human β-defensin-2 in human keratinocytes Am J Physiol Cell Physiol 293 2007 C1916 C1923
24. N. Kanda, and S. Watanabe Increased serum human β-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M Immunobiology 217 2012 436 445
25. H. Carlsson, M. Yhr, S. Petersson, N. Collins, K. Polyak, and C. Enerbäck Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidants Cancer Biol Ther 4 2005 998 1005
26. K. Boniface, C. Diveu, F. Morel, N. Pedretti, J. Froger, E. Ravon, M. Garcia, E. Venereau, L. Preisser, E. Guignouard, G. Guillet, G. Dagregorio, J. Pène, J.P. Moles, H. Yssel, S. Chevalier, F.X. Bernard, H. Gascan, and J.C. Lecron Oncostatin M secreted by skin infiltrating T lymphocytes is a potent keratinocyte activator involved in skin inflammation J Immunol 178 2007 4615 4622
27. N. Kanda, R. Kano, T. Ishikawa, and S. Watanabe The antimycotic drugs itraconazole and terbinafine hydrochloride induce the production of human β-defensin-3 in human keratinocytes Immunobiology 216 2011 497 504
28. K. Park, P.M. Elias, Y. Oda, D. Mackenzie, T. Mauro, W.M. Holleran, and Y. Uchida Regulation of cathelicidin antimicrobial peptide expression by an endoplasmic reticulum (ER) stress signaling, vitamin D receptor-independent pathway J Biol Chem 286 2011 34121 34130
29. J.R. Revollo, A. Körner, K.F. Mills, A. Satoh, T. Wang, A. Garten, B. Dasgupta, Y. Sasaki, C. Wolberger, R.R. Townsend, J. Milbrandt, W. Kiess, and S. Imai Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab 6 2007 363 375
30. T. Romacho, V. Azcutia, M. Vázquez-Bella, N. Matesanz, E. Cercas, J. Nevado, R. Carraro, L. Rodríguez-Mañas, C.F. Sánchez-Ferrer, and C. Peiró Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity Diabetologia 52 2009 2455 2463
31. N. Busso, M. Karababa, M. Nobile, A. Rolaz, F. Van Gool, M. Galli, O. Leo, A. So, and T. De Smedt Pharmacological inhibition of nicotinamide phosphoribosyltransferase/visfatin enzymatic activity identifies a new inflammatory pathway linked to NAD PLoS One 3 2008 e2267
32. T.B. Dahl, A. Yndestad, M. Skjelland, E. Øie, A. Dahl, A. Michelsen, J.K. Damås, S.H. Tunheim, T. Ueland, C. Smith, B. Bendz, S. Tonstad, L. Gullestad, S.S. Frøland, K. Krohg-Sørensen, D. Russell, P. Aukrust, and B. Halvorsen Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 2007 972 980
33. C. Jacques, M. Holzenberger, Z. Mladenovic, C. Salvat, E. Pecchi, F. Berenbaum, and M. Gosset Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity J Biol Chem 287 2012 15100 15108
34. A. Fukuhara, M. Matsuda, M. Nishizawa, K. Segawa, M. Tanaka, K. Kishimoto, Y. Matsuki, M. Murakami, T. Ichisaka, H. Murakami, E. Watanabe, T. Takagi, M. Akiyoshi, T. Ohtsubo, S. Kihara, S. Yamashita, M. Makishima, T. Funahashi, S. Yamanaka, R. Hiramatsu, Y. Matsuzawa, and I. Shimomura Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430 Retraction in Science 2007, 318:565
35. H. Takahashi, H. Tsuji, Y. Hashimoto, A. Ishida-Yamamoto, and H. Iizuka Serum cytokines and growth factor levels in Japanese patients with psoriasis Clin Exp Dermatol 35 2010 645 649
36. H. Nakajima, K. Nakajima, M. Tarutani, R. Morishige, and S. Sano Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients Arch Dermatol Res 303 2011 451 455
37. C. Bonifati, M. Carducci, P. Cordiali Fei, E. Trento, G. Sacerdoti, M. Fazio, and F. Ameglio Correlated increases of tumour necrosis factor-alpha, interleukin-6 and granulocyte monocyte-colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity Clin Exp Dermatol 19 1994 383 387
38. F. Ameglio, C. Bonifati, M. Pietravalle, and M. Fazio Interleukin-6 and tumour necrosis factor levels decrease in the suction blister fluids of psoriatic patients during effective therapy Dermatology 189 1994 359 363
39. A.F. Gombart, N. Borregaard, and H.P. Koeffler Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3 FASEB J 19 2005 1067 1077